Episode Details
Back to Episodes
The Weekly: Mortgage rates hit 6%, the US$200bn pill race and why we hold on to bad investments
Description
UK mortgage rates have hit 6% for the first time since Liz Truss’s mini-budget, yet the Bank of England hasn’t raised rates. So who’s pushing them up, and why does it matter even if you don’t own a home?
With Vic on her way home to New Zealand, our lead investor Nicole Bremner steps in alongside Soph to explain.
Then, the race to turn weight-loss jabs like Ozempic into a pill. It could more than double the number of people using them, and Nicole shares how to invest in a trend like this without having to pick the one winning drug.
Plus, a listener is losing money every month on a house she bought with her brother. Nicole has been in the same position with one of her own properties, and explains why so many of us hold on to bad investments for far too long.
Wondering whether an investment actually lines up with your values? 👉 Submit your money and morals question to The Ethical Hotline: https://form.typeform.com/to/BZHujjGM
Credits:
Hosts: Sophie Hallwright & Vic Harris
Editor: Kate Callaghan
Social & Digital Manager: Lucy Munro
Leave us a message on The Curve Hotline 💌☎️
For more from The Curve:
Instagram: https://www.instagram.com/thecurveplatform/?hl=en
Substack: https://thecurveplatform.substack.com/
Website: https://thecurveplatform.com/
The Curve Investments: https://thecurveinvestments.co.nz/
YouTube: https://www.youtube.com/channel/UCFT_HdjhtoRIwPTmQy2TNLw
TikTok: https://www.tiktok.com/@thecurveplatform
Chapters
- 00:00:00 Coming up in this episode …
- 00:00:56 Pathfinder x The Curve
- 00:01:22 In the red or the green?
- 00:04:47 What’s happening to mortgage rates?
- 00:14:09 Community Question
- 00:22:40 Pathfinder x The Curve
- 00:23:16 How to ride the peptide boom?
- 00:36:46 Thanks for listening!
- 00:39:06 Financial Disclaimer
Disclaimer: Raising The Curve has been prepared solely for informational and educational purposes. Any information provided and serviced described in this website are intended to be of general nature and provide general information only. The opinions expressed by The Curve do not constitute investment advice.